NCT01438918View on ClinicalTrials.gov

X-Ray Study Investigating The Safety And Efficacy Of SD-6010 In Subjects With Osteoarthritis Of The Knee

PHASE3WithdrawnINTERVENTIONAL

0

Timeline

Start Date

March 31, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Knee Osteoarthritis

Interventions

DRUG

SD-6010

200 mg tablets once a day for 2 years

DRUG

SD-6010

50 mg tablets once a day for 2 years

DRUG

Placebo

Placebo tablets once a day for 2 years

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY